Tag: Catalent

Biology

Catalent Biologics Launches GPEx® Boost Cell Line Expression Technology to Improve Titers and Cell-Specific Productivity

Newsemia
SOMERSET, N.J. (PRWEB) November 04, 2019 Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, gene therapies, and...
Biology

Catalent to Debate Logistics of Delivery and Transportation of Cell and Gene Therapies at HPCLC

Newsemia
SOMERSET, N.J. (PRWEB) October 22, 2019 Catalent, a global leader in clinical supply services, today announced that Ann McMahon, Program Director, Clinical Supply Services and...
Biology

Catalent and Minerva Neurosciences Enter Commercial Supply Agreement for Schizophrenia Drug Roluperidone

Newsemia
SOMERSET, N.J. and WALTHAM, Mass. (PRWEB) September 24, 2019 Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics,...
Biology

Advantages of Singapore as a Clinical Supply Hub to be Discussed by Catalent at Accelerating Clinical Trials in Asia Conference

Newsemia
SOMERSET, N.J. (PRWEB) September 17, 2019 Catalent, a global leader in clinical supply services, today announced that Julie Delaney, Director, Project and Clinical Supplies Management,...
Biology

Flexible Filling and Adoption of ‘Ready-to-Use’ Technologies to be Discussed by Catalent Biologics at the Pharma Forum

Newsemia
SOMERSET, N.J. (PRWEB) September 10, 2019 Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, gene therapies, and...
Biology

Catalent Expert to Discuss the Importance of Formulation to Benefit Diabetes Patients at NLS Days

Newsemia
SOMERSET, N.J. (PRWEB) September 03, 2019 Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, gene therapies, and...
Biology

Catalent Biologics Announces Agreement to Provide Additional Production of Approved Gene Therapy Treatment for Spinal Muscular Atrophy

Newsemia
SOMERSET, N.J. (PRWEB) July 16, 2019 Catalent Biologics today announced a long-term strategic agreement for the development and manufacturing of Zolgensma® (onasemnogene abeparvovec-xioi), an AveXis...
Biology

Patient-Focused Drug Delivery to be Presented by Catalent at PODD

Newsemia
SOMERSET, N.J. (PRWEB) October 17, 2018 Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer...
Biology

Lipid-Based Drug Delivery in Modern Pharmaceutical Development to be Presented by Catalent and BASF at Forthcoming Workshop

Newsemia
SOMERSET, N.J. (PRWEB) September 20, 2018 Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer...

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy